by Noah Blaine

Pfizer Announces Positive Preliminary Results from a Proof-of-Concept Phase 2 Study (B7471003) of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Otitis Media in Healthy Infants

Additionally, Pfizer Has Completed Enrollment of its Phase 3 Studies for its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Inv

source https://finance.yahoo.com/news/pfizer-announces-positive-preliminary-results-120000622.html?.tsrc=rss

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.